# Adebrelimab and Chidamide for Pancreatic Cancer

Source: https://onco.cc/trials/nct06584227/  
OnCo record `nct06584227` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of adebrelimab and gemcitabine in pancreatic cancer, run by Liu Xiufeng, now recruiting.

## Summary

Adebrelimab and Chidamide for Pancreatic Cancer is a phase 2, interventional study registered as NCT06584227 by Liu Xiufeng, with a registry enrolment figure of 45 participants, started 2024-09-10 and due to reach its primary completion in 2026-07-10. Interventions recorded: Adebrelimab and Chidamide Combined with Gemcitabine and S1. Conditions listed: Pancreatic Cancer, Adult. Primary outcome: Progression free survival. Pancreatic eligibility wording from the registry: "Histologically or cytologically confirmed pancreatic cancer (originating from the ductal epithelium of the pancreas) with clinically documented unresectable locally advanced or metastatic pancreatic cancer (stage III/IV according to the TNM stage of AJCC 8 pancreatic cancer);". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Also known as: ACPC
- Tags: ctgov-ingest; pancreatic-deep-dive
- Registry id: NCT06584227
- Phase: 2
- Setting: A Single-Arm, Multicenter, Open, Phase II Clinical Study of Adebrelimab and Chidamide in Combination With Gemcitabine and S1 for the First-Line Treatment of Locally Advanced or Metastatic Pancreatic Cancer
- Sponsor: Liu Xiufeng
- Enrolled: 45

## Sources

- ClinicalTrials.gov NCT06584227: https://clinicaltrials.gov/study/NCT06584227

## Connected records

- cancers: [Locally advanced unresectable pancreatic ductal adenocarcinoma](https://onco.cc/cancers/locally-advanced-pdac/), [Metastatic pancreatic ductal adenocarcinoma](https://onco.cc/cancers/metastatic-pdac/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/)
- drugs: [Adebrelimab](https://onco.cc/drugs/adebrelimab/), [Gemcitabine](https://onco.cc/drugs/gemcitabine/)
- terms: [Pancreatic cancer trials open today (registry snapshot and UK sites)](https://onco.cc/terms/pancreatic-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06584227.json